on 1 Jul 2020
Last Applicant/ Owned by
Ring Therapeutics, Inc.
140 First Street
Cambridge, MA, 02141
Serial Number
UK00004118326 filed on 1st Jul 2020
Registration Number
UK00004118326 registered on
20th Nov 2020
Correspondent Information
Keltie LLP
No1 London Bridge
London,
SE1 9BA
Encapsulated nucleic acid agents for medical use; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/auto inflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy.
UK00004118326
Word
Individual